Merontos, Menzl Mae V.

HRN: 13 21 16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
CEFUROXIME 500MG (TAB)
05/28/2023
06/03/2023
PI
500mg
BID
Uti
Checking Final Appropriateness 
05/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/28/2023
06/04/2023
IV
500mg
Q8
Amoebiasis
Checking Final Appropriateness 
05/30/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/30/2023
06/06/2023
IV
500mg
Q6hrs
Intestinal Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: